Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
17.29
Oct 09 • 10:53 AM ET Dollar change+0.39 Percentage change(2.30%)
Index
RUT
Market Cap
875.66M
Enterprise Value
757.26M
Income
-40.88M
Sales
186.45M
Book/sh
8.77
Cash/sh
7.83
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
738
IPO
Jan 31, 2005
P/E
-
Forward P/E
-
PEG
-
P/S
4.70
P/B
1.97
P/C
2.21
P/FCF
-
EV/EBITDA
-
EV/Sales
4.06
Quick Ratio
1.98
Current Ratio
2.08
Debt/Eq
0.47
LT Debt/Eq
0.09
Option/Short
Yes / Yes
EPS (ttm)
-0.82
EPS next Y
-0.64
EPS next Q
-0.18
EPS this Y
-156.31%
EPS next Y
18.20%
EPS next 5Y
-
EPS past 3/5Y
-0.23% 13.68%
Sales past 3/5Y
-9.45% 17.49%
EPS Y/Y TTM
17.42%
Sales Y/Y TTM
-8.01%
EPS Q/Q
24.23%
Sales Q/Q
7.74%
Insider Own
4.39%
Insider Trans
-10.34%
Inst Own
90.20%
Inst Trans
3.31%
ROA
-4.30%
ROE
-6.54%
ROIC
-6.17%
Gross Margin
40.16%
Oper. Margin
-21.25%
Profit Margin
-21.92%
SMA20
0.39%
SMA50
6.25%
SMA200
35.68%
Trades
Shs Outstand
50.65M
Shs Float
48.43M
52W High
18.36 -5.83%
52W Low
7.61 127.18%
Volatility
4.37% 3.57%
ATR (14)
0.60
RSI (14)
54.74
Beta
1.90
Rel Volume
0.38
Avg Volume
641.16K
Volume
61,481
Perf Week
-0.81%
Perf Month
13.22%
Perf Quarter
10.05%
Perf Half Y
78.79%
Perf YTD
80.09%
Perf Year
73.93%
Perf 3Y
42.29%
Perf 5Y
-73.64%
Perf 10Y
757.83%
Prev Close
16.90
Price
17.29
Change %
2.30%
Date Action Analyst Rating Change Price Target Change
Aug-06-25Upgrade Leerink Partners Market Perform → Outperform $16
Aug-06-25Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jul-22-25Resumed Stephens Overweight $13
Mar-24-25Upgrade UBS Neutral → Buy $10
Dec-19-24Initiated Guggenheim Buy $11
Aug-07-24Downgrade Jefferies Buy → Hold $20 → $8
Jul-31-24Upgrade B. Riley Securities Neutral → Buy $19 → $15
May-03-24Downgrade B. Riley Securities Buy → Neutral $22 → $19
Apr-04-24Resumed Jefferies Buy $17 → $21
Mar-13-24Reiterated Needham Buy $19 → $18
Aug-07-26 08:30AM
01:05AM
Aug-06-26 04:05PM
Jul-23-26 08:00AM
Jun-25-26 08:00AM
08:23PM Loading…
May-04-26 08:23PM
04:05PM
Apr-20-26 04:05PM
Mar-04-26 08:30AM
12:00AM
Mar-03-26 07:02PM
05:25PM
04:05PM
Feb-18-26 08:10AM
Feb-17-26 08:00AM
08:30AM Loading…
Feb-11-26 08:30AM
08:16AM
Nov-05-25 12:09AM
Nov-04-25 05:50PM
04:05PM
Nov-03-25 08:01AM
Oct-30-25 08:30AM
Oct-21-25 08:00AM
Oct-17-25 04:09AM
Oct-07-25 08:30AM
Oct-01-25 08:30AM
Aug-06-25 03:32AM
Aug-05-25 06:35PM
04:19PM
Aug-04-25 05:55PM
10:02AM Loading…
10:02AM
Jul-31-25 05:25PM
10:00AM
Jul-29-25 10:00AM
Jul-25-25 09:55AM
Jul-22-25 08:00AM
Jul-08-25 08:00AM
07:45AM
Jul-04-25 12:00PM
Jun-27-25 12:00PM
Jun-12-25 08:00AM
May-28-25 09:55AM
May-12-25 09:55AM
May-08-25 03:34AM
May-07-25 07:15PM
07:15PM
05:20PM
04:05PM
May-06-25 09:35AM
Apr-30-25 10:01AM
Apr-24-25 08:30AM
Apr-10-25 10:39AM
Apr-04-25 06:03AM
Mar-31-25 03:11PM
09:06AM
08:09AM
Mar-26-25 09:15AM
Mar-18-25 07:59PM
Mar-13-25 07:28AM
Mar-12-25 08:30AM
Mar-05-25 02:10AM
Mar-04-25 05:35PM
04:10PM
Mar-03-25 07:18AM
Feb-18-25 08:30AM
Jan-21-25 08:30AM
Jan-14-25 08:30AM
Jan-06-25 08:30AM
Nov-12-24 08:30AM
Nov-08-24 04:03PM
Nov-07-24 05:55PM
04:05PM
Nov-06-24 07:37AM
Oct-31-24 10:01AM
Oct-29-24 08:30AM
Oct-22-24 08:30AM
Oct-21-24 08:30AM
Oct-15-24 08:30AM
Oct-07-24 08:30AM
Sep-25-24 08:30AM
Sep-09-24 05:28AM
Aug-19-24 03:27AM
Aug-06-24 07:00PM
04:15PM
04:05PM
Jul-23-24 08:30AM
Jul-12-24 02:46AM
Jul-09-24 09:35AM
Jun-20-24 08:30AM
May-17-24 02:33AM
May-08-24 02:54PM
04:03AM
May-07-24 09:56PM
06:18PM
04:08PM
May-03-24 10:12AM
06:41AM
Apr-30-24 08:30AM
Apr-25-24 10:02AM
Mar-13-24 09:16AM
Cryoport, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
MBAJerrell W. Shelton
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHELTON JERRELLPresident, CEOAug 11 '26Sale14.9128,800429,3851,201,814Aug 11 06:49 PM
JERRELL W SHELTONDirectorAug 11 '26Proposed Sale14.8228,800426,816Aug 11 04:31 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Option Exercise4.8033,600161,280143,319Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Option Exercise4.801,4006,720111,119Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Sale14.4733,600486,239109,719Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Sale15.231,40021,324109,719Jun 12 06:38 PM
EDWARD ZECCHINIOfficerJun 11 '26Proposed Sale14.4733,600486,239Jun 11 04:09 PM
EDWARD ZECCHINIOfficerJun 10 '26Proposed Sale15.231,40021,324Jun 10 04:15 PM
STEFANOVICH ROBERTChief Financial OfficerJun 04 '26Sale16.27169,4272,756,984109,850Jun 08 09:11 PM
Mandalam RamkumarDirectorJun 08 '26Sale15.4423,214358,45267,894Jun 08 09:05 PM
RAMKUMAR MANDALAMDirectorJun 08 '26Proposed Sale15.4423,214358,452Jun 08 04:17 PM
STEFANOVICH ROBERTOfficerJun 04 '26Proposed Sale16.50169,4272,795,546Jun 03 04:35 PM
SHELTON JERRELLPresident, CEOApr 21 '26Option Exercise1.87104,007194,4931,230,614Apr 23 08:00 PM
SHELTON JERRELLPresident, CEOApr 06 '26Option Exercise1.8750,00093,5001,126,607Apr 08 06:32 PM
STEFANOVICH ROBERTChief Financial OfficerMar 23 '26Sale8.181,0948,949279,277Mar 25 08:01 PM
SHELTON JERRELLPresident, CEOMar 23 '26Option Exercise1.8725,00046,7501,076,607Mar 25 08:00 PM
SHELTON JERRELLPresident, CEOMar 23 '26Sale8.182,89423,6731,051,607Mar 25 08:00 PM
Sawicki Mark WChief Scientific OfficerMar 23 '26Sale8.181,34110,969102,356Mar 25 08:00 PM
ZECCHINI EDWARD JSee RemarksMar 16 '26Sale8.002,01416,112109,719Mar 17 08:01 PM
SHELTON JERRELLPresident, CEOMar 16 '26Sale8.007,91863,3441,054,501Mar 17 08:00 PM
Sawicki Mark WChief Scientific OfficerMar 16 '26Sale8.003,23525,880103,697Mar 17 08:00 PM
STEFANOVICH ROBERTChief Financial OfficerMar 12 '26Option Exercise1.8787,188163,042294,401Mar 16 09:35 PM
STEFANOVICH ROBERTChief Financial OfficerMar 12 '26Sale7.7638,700300,386255,701Mar 16 09:35 PM
STEFANOVICH ROBERTChief Financial OfficerMar 16 '26Sale8.002,74321,944280,371Mar 16 09:35 PM
ROBERT S. STEFANOVICHOfficerMar 12 '26Proposed Sale7.7638,700300,386Mar 12 04:17 PM
Mandalam RamkumarDirectorDec 10 '25Sale9.9911,570115,54080,758Dec 12 05:30 PM
RAMKUMAR MANDALAMDirectorDec 10 '25Proposed Sale9.9911,570115,540Dec 10 04:10 PM